Industry News
Pharmaceutical Industry News
FDA blasts Toyobo for subpar particulate investigation and data integrity breaches
FDA blasts Toyobo for subpar particulate investigation and data integrity breaches fkansteiner Thu, 08/26/2021 - 09:12
Pfizer taps McKinsey veteran Malik as its new dealmaking czar
Pfizer taps McKinsey veteran Malik as its new dealmaking czar aliu Thu, 08/26/2021 - 05:34
Weekly Health Quiz: Covid, Aloe and Heartburn
Test your knowledge of this week’s health news.
GSK’s latest meningitis B campaign taps first spokescelebrity: ‘Punky Brewster,’ now mom of 4
GSK's latest meningitis B campaign taps first spokescelebrity: 'Punky Brewster,' now mom of 4 bbulik Wed, 08/25/2021 - 23:03
Ascendis crosses FDA finish line with once-weekly growth hormone—but Pfizer is hot on its trail
Ascendis crosses FDA finish line with once-weekly growth hormone—but Pfizer is hot on its trail fkansteiner Wed, 08/25/2021 - 19:09
Moderna probes reports of COVID-19 vaccine contamination in Japan
Moderna probes reports of COVID-19 vaccine contamination in Japan kdunleavy Wed, 08/25/2021 - 16:11
Seeking approval for a 3rd dose, Pfizer and BioNTech take their COVID-19 booster data to the FDA
Seeking approval for a 3rd dose, Pfizer and BioNTech take their COVID-19 booster data to the FDA kdunleavy Wed, 08/25/2021 - 14:48
Catalent, Delpharm manufacturing sites win EU’s blessing to produce millions of Pfizer, Moderna COVID-19 vaccine doses
Catalent, Delpharm manufacturing sites win EU's blessing to produce millions of Pfizer, Moderna COVID-19 vaccine doses nhigginsdunn Wed, 08/25/2021 - 14:04
With trial results in infants, Merck advances next-gen pneumococcal shot Vaxneuvance in race against Pfizer
With trial results in infants, Merck advances next-gen pneumococcal shot Vaxneuvance in race against Pfizer kdunleavy Wed, 08/25/2021 - 09:22
Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original vaccination
Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original vaccination fkansteiner Wed, 08/25/2021 - 09:13
GSK propels ‘Our Way Forward’ ovarian cancer campaign, doubling down on patient stories during the pandemic
GSK propels 'Our Way Forward' ovarian cancer campaign, doubling down on patient stories during the pandemic bbulik Wed, 08/25/2021 - 09:07
Sanofi, GSK and Seqirus prep for near-record flu shot sales as COVID’s delta variant cooks up ‘recipe for disaster’
Sanofi, GSK and Seqirus prep for near-record flu shot sales as COVID's delta variant cooks up 'recipe for disaster' nhigginsdunn Tue, 08/24/2021 - 18:10
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says fkansteiner Tue, 08/24/2021 - 14:26
J&J, Bayer’s Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquis
J&J, Bayer's Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquis nhigginsdunn Tue, 08/24/2021 - 11:31
Manufacturing issues force delay for PolarityTE’s skin repair hopeful
Manufacturing issues force delay for PolarityTE's skin repair hopeful kdunleavy Tue, 08/24/2021 - 11:17
Regeneron’s bid for high-dose Eylea scores early win, but the ‘all important’ data are still to come: analysts
Regeneron's bid for high-dose Eylea scores early win, but the 'all important' data are still to come: analysts fkansteiner Tue, 08/24/2021 - 11:15
Pharma’s reputation drops again. Could it foreshadow a return to the bottom?
Pharma's reputation drops again. Could it foreshadow a return to the bottom? bbulik Tue, 08/24/2021 - 10:44
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more fkansteiner Tue, 08/24/2021 - 09:21
CRISPR pioneer helps create gene-editing delivery system
CRISPR pioneer helps create gene-editing delivery system ntaylor Tue, 08/24/2021 - 09:17
Novartis’ Kymriah flops in earlier lymphoma use, where Gilead, Bristol Myers CAR-T rivals succeeded
Novartis' Kymriah flops in earlier lymphoma use, where Gilead, Bristol Myers CAR-T rivals succeeded aliu Tue, 08/24/2021 - 07:32